Cladribine Tablets as an Exit Therapy Strategy

Clinical trial NCT06887426 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06887426
Sponsor: University Hospital, Strasbourg, France
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Multiple Sclerosis Relapsing Remitting Multiple Sclerosis Secondary Progressive Multiple Sclerosis

Start date: 2025-06-01
Primary completion: 2025-12-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.